SCHEMBL19904397

SCHEMBL19904397

CCCCNCCCc1ccc(OC2CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.45
CRBN Q96SW2 1/20 0.45
ALDH1A1 P00352 2/20 0.44
TSHR P16473 1/20 0.44
S1PR2 O95136 3/20 0.43
S1PR1 P21453 3/20 0.43
S1PR3 Q99500 3/20 0.43
S1PR4 O95977 2/20 0.43
ACACB O00763 3/20 0.42
SIGMAR1 Q99720 2/20 0.41
HRH3 Q9Y5N1 1/20 0.41
DRD2 P14416 2/20 0.41
DRD4 P21917 2/20 0.41
DRD3 P35462 2/20 0.41
NAAA Q02083 2/20 0.40
KDM1A O60341 1/20 0.40
ALOX12 P18054 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904619 0.85 DRD2 (0.43) ALDH1A1TSHRS1PR1S1PR3ACACB
SCHEMBL19904450 0.78 MEN1 (0.39) S1PR2S1PR1S1PR3S1PR4
SCHEMBL2091100 0.76 NAAA (0.46) DDB1CRBNALDH1A1HRH3NAAA
SCHEMBL2092643 0.75 NAAA (0.47) DDB1CRBNALDH1A1HRH3NAAA
SCHEMBL8276621 0.74 TP53 (0.42) DDB1CRBNALDH1A1TSHRHRH3
SCHEMBL21122690 0.74 HRH3 (0.50) HRH3DRD3
SCHEMBL19904472 0.74 HRH1 (0.42) DDB1CRBNALDH1A1TSHR
SCHEMBL19904683 0.73 SIGMAR1 (0.38) ALDH1A1S1PR2S1PR1S1PR3S1PR4
SCHEMBL12188700 0.73 DDB1 (0.50) DDB1CRBNALDH1A1TSHRACACB
SCHEMBL4964015 0.72 ALDH1A1 (0.50) ALDH1A1TSHRACACBHRH3ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3912977-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES BioMarin Pharmaceutical Inc. (US) 2021-11-24 EP disclosed
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed